Chlamydia trachomatis during pregnancy. To screen or not to screen?
A critical review of the literature on screening for and treating Chlamydia trachomatis during pregnancy suggests that all pregnant women at high risk of chlamydial infection, or from a population where infection is prevalent, should be screened and treated. This will help reduce chlamydial infections in infants and may decrease adverse outcomes of pregnancy.
Carroll
J C
JC
Family and Community Medicine, University of Toronto.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002690:Chlamydia Infections / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D002692:Chlamydia trachomatis; D005260:Female; D052776:Female Urogenital Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D005455:Fluorescent Antibody Technique / Q000592:standards; D006801:Humans; D007124:Immunoenzyme Techniques / Q000592:standards; D008403:Mass Screening / Q000379:methods / Q000592:standards*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D011256:Pregnancy Outcome; D015995:Prevalence; D012307:Risk Factors; D012680:Sensitivity and Specificity
D000900:Anti-Bacterial Agents